{"id":"W2478932238","doi":"10.1182/blood-2016-03-707596","title":"Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Onyx Pharmaceuticals; Agence Nationale de la Recherche; National Cancer Institute; Celgene; Amgen","keywords":"Carfilzomib; Multiple myeloma; Internal medicine; Oncology; Medicine; Overall survival; Progression-free survival; Cytogenetics; Lenalidomide; Biology; Genetics; Chromosome","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003167073,0.0002791444,0.0005253632,0.0001965402,0.0001347667,0.0001788553,0.0001583104,0.0001812212,0.0003990757],"category_scores_gemma":[0.000553277,0.00008597195,0.0002595625,0.0001876453,0.000118299,0.0001351606,0.0001269014,0.0004015765,0.00008708379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003046795,"about_ca_system_score_gemma":0.0002143465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008229959,"about_ca_topic_score_gemma":0.002274082,"domain_scores_codex":[0.9998924,0.00003192923,0.000009086551,0.00001446298,0.00002771172,0.00002452347],"domain_scores_gemma":[0.9998275,0.00004235611,0.00005410428,0.000009811563,0.0000103521,0.00005576474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0720996,0.004204452,0.2525807,0.0004902681,0.001305728,0.0009954527,0.0003040256,0.002931467,0.0648396,0.0001424786,0.005539169,0.5945672],"study_design_scores_gemma":[0.006503254,0.03916036,0.9309577,0.00004349035,0.0006912489,0.002802344,0.0000932669,0.002279719,0.009483943,0.0002388345,0.007717239,0.00002865466],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959358,0.003357837,0.00006268403,0.0001443065,0.00001865602,0.00001419053,0.00004608923,0.00002892197,0.0003915457],"genre_scores_gemma":[0.9989071,0.0005916056,0.0001077246,0.00007316702,0.00002895088,0.000006643321,0.0001274752,0.000001526378,0.0001558299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008229959,"threshold_uncertainty_score":0.002210677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01630979111809902,"score_gpt":0.2668410858789262,"score_spread":0.2505312947608273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}